Patients With Tki Naïve Metastatic Non Small Cell Lung Cancer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Xiuning Le, MD, PhD, discusses findings from the interim analysis of the phase 2 RAMOSE trial in patients with TKI-naïve metastatic non–small cell lung cancer harboring EGFR mutations.

United statesXiuning leDepartment of thoracic headDivision of internal medicineUniversity of texas md anderson cancer centerNeck medical oncologyInternal medicineCancer centerThe university of texas md anderson cancer centerRamose trialPatients with tki naïve metastatic non small cell lung cancer